Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.45 |
| ▸ | SNCA | P37840 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13721705 | 0.90 | MAPK1 (0.34) | LPLLIPGSNCA | |
| SCHEMBL119228 | 0.87 | LPL (0.44) | LPLLIPG | |
| SCHEMBL27949202 | 0.84 | LPL (0.36) | LPLLIPG | |
| SCHEMBL29982398 | 0.81 | LPL (0.34) | LPLLIPGSNCA | |
| SCHEMBL29982275 | 0.80 | LPL (0.33) | LPLLIPGSNCA | |
| SCHEMBL20984011 | 0.79 | LIPG (0.51) | LPLLIPGSNCAPDGFRBKDR | |
| SCHEMBL20984001 | 0.78 | LIPG (0.61) | LPLLIPGSNCAPDGFRBKDR | |
| SCHEMBL20928226 | 0.77 | SNCA (0.52) | LPLLIPGSNCA | |
| SCHEMBL1829293 | 0.77 | LPL (0.35) | LPLLIPGSNCA | |
| SCHEMBL17669989 | 0.76 | PDGFRB (0.35) | LPLLIPGSNCAPDGFRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109791984-B | Material for photoelectric conversion element for imaging element and photoelectric conversion element containing same | 日本化药株式会社 | 2023-02-07 | — | — | CN | disclosed |
| US-11374044-B2 | Material for photoelectric conversion element for use in imaging element, and photoelectric conversion element including same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2022-06-28 | — | — | US | disclosed |
| US-10937964-B2 | Organic semiconductor material | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2021-03-02 | — | — | US | disclosed |
| US-20190157321-A1 | Material for Photoelectric Conversion Element for Use in Imaging Element, and Photoelectric Conversion Element Including Same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2019-05-23 | — | — | US | disclosed |
| US-20140081028-A1 | ORGANIC SEMICONDUCTOR MATERIAL | DIC CORPORATION | 2014-03-20 | — | — | US | disclosed |
| US-20140081028-A1 | ORGANIC SEMICONDUCTOR MATERIAL | DIC CORPORATION | 2014-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11374044-B2 | Material for photoelectric conversion element for use in imaging element, and photoelectric conversion element including same | SLC19A1, SLC46A1, SLC19A2 | LPL 2997/4885LIPG 1535/4885SNCA 2841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.